Nested Lands is a survival/RPG set on a post-plague medieval world full of cruelty and despair. Gather survivors, build a settlement, craft, master your skills, survive, and endure alone or in online ...

Nested Lands will have all of its planned core mechanics in place when it hits Early Access this month. In fact, refining those mechanics is part of why the game is launching just about a month later ...

NASHVILLE, Tenn. (WSMV) - When the power went out in Shanna Strassberg’s Sylvan Park neighborhood, she and her neighbors were in it together. “I felt like I had prepared well enough,” Strassberg said.

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Andres Almiray, a serial open-source ...

Survival settlement RPG Nested Lands will launch in Early Access for PC via Steam, Epic Games Store, and GOG, on January 23, META Publishing and developer 1 Million Bits Horde announced. Console ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Researchers at Google have developed a new AI paradigm aimed at solving one of the biggest limitations in today’s large language models: their inability to learn or update their knowledge after ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...